Global /China /Healthcare /Medical Care Facilities /300642

Tellgen Corp.

300642

• SHE: 300642 • Delayed

16.51CNY 0.3%

2.44 USD

As of 5 June 2026, Tellgen Corp. has a market cap of $388.7M USD, ranking #16883 globally and #5272 in China. It ranks #1534 in the Healthcare sector, and #171 in the Medical Care Facilities industry.

Global Rank

16883

Country Rank

5272

Sector Rank

1534

Industry Rank

171

Key Stats

Market Cap

$388.7MUSD

2.63B CNY

Enterprise Value

$372.51MUSD

2.52B CNY

Revenue (TTM)

$54.89MUSD

371.54M CNY

EBITDA (TTM)

$13.48MUSD

91.25M CNY

Net Income (TTM)

-$361.11KUSD

-2.44M CNY

EBITDA Margin

25%

Profit Margin

-0.7%

PS Ratio

7.1

PB Ratio

1.8

EV/EBITDA

26.5

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Jian Er Yao open_in_new

Employees

522

Founded

2003

Website

tellgen.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.3%	-1.8%	-1.6%	-16%	-28%	-10%	26%	-24%	-56%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300642 上海透景生命科技股份有限公司 Class A ISIN: CNE100002P42 Shares Out.: Shares Outstanding: 159.861M¹ Shares Float: 145.889M² TV: TradingView: SZSE: 300642 SA: Stock Analysis: SHE: 300642 YF: Yahoo Finance: 300642.SZ GF: Google Finance: SHE: 300642 BA: Barron's: 300642 MS: Morningstar: XSHE: 300642	16.51 CNY	TV: TradingView: SZSE: 300642 SA: Stock Analysis: SHE: 300642 YF: Yahoo Finance: 300642.SZ GF: Google Finance: SHE: 300642 BA: Barron's: 300642 MS: Morningstar: XSHE: 300642

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tellgen Corp.

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.

Similar Companies

Industry: Medical Care Facilities (China)

Name	Market Cap (USD) diff.	PE	Country
Aier Eye Hospital Group Co., Ltd. SHE: 300015	$15.03B 101.77B CNY 4K%	30.1	China
Meinian Onehealth Healthcare Holdings Co., Ltd. SHE: 002044	$3.02B 20.46B CNY 678%	75.1	China
Ping An Healthcare and Technology Company Ltd. SHEK: 1833	$2.94B 23.07B HKD 658%	54.2	China
Topchoice Medical Co., Inc. SSE: 600763	$2.86B 19.35B CNY 635%	38.6	China
Sanbo Hospital Management Group Ltd. SHE: 301293	$1.92B 12.97B CNY 393%	218.8	China
Guangzhou Kingmed Diagnostics Group Co., Ltd. SSE: 603882	$1.87B 12.65B CNY 381%	-	China

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.22B 852.82B AED 60K%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 25K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.65B 22.97B EUR 7K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.54B 22.02B EUR 6K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.47B 84.42B SAR 6K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 5K%	24.6	United States

chevron_leftBack